Reshcon Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 0.60 M
- Revenue Growth 9.90%
- Profit Growth 95.74%
- Ebitda 129.52%
- Net Worth 17.79%
- Total Assets 181.32%
About Reshcon Healthcare
Reshcon Healthcare Private Limited (RHPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 October 2014 and has a history of Ten years and four months. Its registered office is in Buldhana, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.60 M.
Sachin Chaudhari and Atmaram Choudhari serve as directors at the Company.
Company Details
- Location
Buldhana, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24100MH2014PTC258806
- Company No.
258806
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Oct 2014
- Date of AGM
29 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Reshcon Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sachin Chaudhari  | Director | 20-Oct-2014 | Current |
| Atmaram Choudhari | Director | 20-Oct-2014 | Current |
Financial Performance of Reshcon Healthcare.
Reshcon Healthcare Private Limited, for the financial year ended 2019, experienced modest growth in revenue, with a 9.9% increase. The company also saw a substantial improvement in profitability, with a 95.74% increase in profit. The company's net worth Soared by an impressive increase of 17.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Reshcon Healthcare?
In 2019, Reshcon Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Amychem Laboratories LlpSachin Chaudhari is a mutual person
Charges (Loans)
₹0.60 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.06 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Dec 2017 | State Bank Of India | ₹0.60 M | Open |
How Many Employees Work at Reshcon Healthcare?
Unlock and access historical data on people associated with Reshcon Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Reshcon Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reshcon Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.